Abstract
Atopic dermatitis, also known as atopic eczema, is a chronic inflammatory skin disease frequently seen in patients with a personal or family history of asthma and allergic rhinitis. There have been extraordinary strides made in the understanding of the immunopathogenesis of allergic diseases. In particular, this constellation of inherited illnesses is associated with activation of a specific group of cytokine genes encompassing IL-3, IL-4, IL-5, IL-13, and granulocyte-macrophage colony-stimulating factor The molecular basis for selective activation of this cytokine gene cluster and their immunological consequences are being investigated However, it is clear that allergic diseases result from a poly-genic inheritance pattern that involves cytokine-gene activation and other less-well-defined gene products as well. In addition, the clinical expression of allergic diseases is highly dependent on a complex interaction between the host and its environment, for example, allergen exposure. This chapter reviews some of these developments and their clinical implications
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Selected references
Abemathy-Carver KJ, Sampson HA, Picker LJ, Leung DYM. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest 1995;95:913–918.
Akdis M, Trautmann A, Klunker S, et al. T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J 2003;17:1026–1035.
Al-Daraji WI, Grant KR, Ryan K, Saxton A, Reynolds NJ. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of cal-cineurin/NFAT activation in human keratinocytes by cyclosporin A. J Invest Dermatol 2002;1 18:779–788.
Babi LFS, Picker U, Soler MTP. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor the cutaneous lymphocyte-associated antigen (CLA). J Exp Med 1995;181:1935–1940.
Barton D, HogenEsch H, Weih F. Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur J Immunol 2000;30(8):2323–2332.
Bieber T, de la Salle H, Wollenberg A, et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (FceRI). J Exp Med 1992;175:1285–1290.
Bochner BS, Klunk DA, Sterbinsky SA, Coffinan RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-I expression in human endothelial cells. J Immunol 1995;154:799–803.
Chan LS, Robinson N, Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 2001;117(4):977–983.
Chan SC, Hanifin JM. Immunopharmacologic aspects of atopic dermatitis. Clin Rev Allergy Immunol 1993;11:523–542.
Chandrasekharappa SC, Rebelsky MS, Fiiak TA, LeBeau MM, Westbrook CA. A long-range restriction map of the interleukin-4 and interleukin 5 linkage group on chromosome 5. Genomics 1990;6:94–99.
Cooke RA, van der Veer A. Human sensitization. J Immunol 1916;1: 201–305.
Cookson WOCM, Hopkin JM. Dominant inheritance of atopic immuno-globulin E responsiveness. Lancet 1988;1:86–88.
Cooper KD. New therapeutic approaches in atopic dermatitis. Clin Rev Allergy Immunol 1993;11(4):543–559.
Giannetti A. Neuropeptides in atopic dermatitis. Curr Probl Dermatol 1999;28:51–55.
Grewe M, Czech W, Morita A, et al. Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol 1998;161(1):415–420.
Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis. J Clin Invest 1994; 94:870–876.
Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980;92:44–47.
Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 2000;115(3):406–413.
Hill LW, Sulzberger MB. Yearbook of Dermatology and Syphilology. Chicago: Year Book Medical Publisher, 1933; pp. 1–70.
Hopp RJ, Bewtra AK, Watt GD, Nair NM, Townley RG. Genetic analysis of allergic disease in twins. J Allergy Clin Immunol 1984;73:265–270.
Jones SM, Sampson HA. The role of allergens in atopic dermatitis. Clin Rev Allergy Immunol 1993;11:471–490.
Kang KF, Tian RM. Atopic dermatitis. An evaluation of clinical and laboratory findings. Int J Dermatol 1987;26:27–32.
Kay AM, Ying S, Vamey V, et al. Messenger RNA expression of cytokine gene cluster, interleulan 3 (IL-3), IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775–778.
Klunker S, Trautmann A, Akdis M, et al. A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. J Immunol 2003; 171:1078–1084.
Kondo H, Ichikawa Y, Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 1998;28:769–779.
Koomen CAFM. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE. Immunology 1990;69:335–341.
Kraft S, Wessendorf JH, Haberstok J, Novak N, Wollenberg A, Bieber T. Enhanced expression and activity of protein-tyrosine kinases establishes a functional signaling pathway only in FcepsilonRIhigh Langerhans cells from atopic individuals. J Invest Dermatol 2002; 119:804–811.
Lacour M, Hauser C. The role of microorganisms in atopic dermatitis. Clin Rev Allergy Immunol 1993;11:491–522.
Lee YA, Wahn U, Kehrt R, et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 2000;26(4): 470–473.
Leiferman KM. A role for eosinophils in atopic dermatitis. J Am Acad Dermatol 2001;45(1 Pt 2):S21–S24.
Leung DY, Bieber T. Atopic dermatitis. Lancet 2003;361(9352):151–160.
Leung DYM. Atopic dermatitis: the skin as a window into the pathogene-sis of chronic allergic diseases. J Allergy Clin Immunol 1995;96: 302–319.
Leung DYM, Geha RS. Clinical and immunologic aspects of the hyper IgE syndrome. In: Hematology Oncology Clinics of North America. Philadelphia: Saunders, 1988; pp. 81–100.
Leung DYM, Travers JB, Norris DA. Superantigens in skin disease. J Invest Dermatol 1995;105:37S–42S.
Leung DYM, Harbeck R, Bina P, Hanifin JM, Reiser RF, Sampson HA. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens. J Clin Invest 1993;92:1374–1380.
Marsh DG, Neely JD, Breazeale DR, et al. Linkage analysis of lL-4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994 264:1152–1156.
Matsumoto M, Ra C, Kawamoto K, et al. IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J Immunol 1999;162(2): 1056–1063.
May CE. Objective clinical laboratory studies of immediate hypersensitiv-ity reactions to foods in asthmatic children. J Allergy Clin Immunol 1976;58:500–515.
Meyers D, Marsh D. Report on a national institute of allergy and infectious diseases sponsored workshop on the genetics of total immunoglobulin E levels in humans. J Allergy Clin Immunol 1981;67:167–170.
Mosmann TR, Cherwinski H, Bond MW, Giedlin MH, Coffinan R. Two types of murine helper T cell clones. 1. Definition according to profiles of lymphokine activities and secretory proteins. J Immunol 1986;136:2348–2357.
Mudde GC, Van Reijsen PC, Boland GJ, et al. Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J Immunol 2001;167:797–804.
Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 2002;46(2 Pt 1):228–241.
Nomura I, Gao B, Boguniewicz M, Darst MD, Travers JB, Leung DYM. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003;112:1195–1202.
Nomura I, Goleva E, Howell MD, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003;171:3262–3269.
Novak N, Kruse S, Kraft S, et al. Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis. J Invest Dermatol 2002;119:870–875.
Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347(15): 1151–1160.
Pastore S, Fanales-Belasio E, Albanesi C, Chinni LM, Giannetti A, Girolomoni G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 1997;99: 3009–3017.
Schnyder UW. Neurodermititis-asthma-rhintis. Eine genetischallergol-ogisch studie. Acta Genet Stat Med 1960;10(Suppl 18):1–106.
Schultz Larsen F, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986;15:487–494.
Shibaki A, Ohkawara A, Shimada S, Ra C, Aiba S, Cooper KD. Expression, but lack of calcium mobilization by high-affinity IgE Fc epsilon receptor I on human epidermal and dermal Langerhans cells. Exp Dermatol 1996;5:272–278.
Shirakawa TS, Li A, Dubowitz M, et al. Association between atopy and variants of the P-subunit of the high affinity Immunoglobulin E receptor. Nat Genet 1994;7:124–129.
Taylor RS, Baadsgaard O, Hammerberg C, Cooper KD. Hyperstimulatory CD1a+CD1b+CD36+Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis. J Immunol 1991;147:3794–3802.
Tsicopoulous A, Hamid Q, Vamey V, et al. Preferential messenger RNA expression of Thl-type cells (IFN-γ+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol 1992;148:2058–2061.
Vercelli D, Jabara HH, Lee B, Woodland N, Geha RS, Leung DYM. Human recombinant interleukin-4 induces FcεR2/CD23 on normal human monocytes. J Exp Med 1988;167:1406–1416.
Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen CG. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 2000;115(4):640–646.
Walley AJ, Chavanas S, Moffatt MF el al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001;29(2):175–178.
Williams HC, Burney PGJ, Pembroke AC, et al. The UK Working Party’s diagnostic criteria for atopic dermatitis III. Independent hospital validation. Br J Dermatol 1994;131:406–416.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this chapter
Cite this chapter
Kang, K., Leung, D.Y.M., Cooper, K.D. (2006). Atopic Dermatitis. In: Runge, M.S., Patterson, C. (eds) Principles of Molecular Medicine. Humana Press. https://doi.org/10.1007/978-1-59259-963-9_97
Download citation
DOI: https://doi.org/10.1007/978-1-59259-963-9_97
Publisher Name: Humana Press
Print ISBN: 978-1-58829-202-5
Online ISBN: 978-1-59259-963-9
eBook Packages: MedicineMedicine (R0)